{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:52:44Z","timestamp":1773298364925,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shriners of North America","award":["85210"],"award-info":[{"award-number":["85210"]}]}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.mehy.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T14:20:47Z","timestamp":1395411647000},"page":"736-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"C.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Burkovskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kuethe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2014.03.015_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/187152610790963528","article-title":"Post-stroke immunodepression and infection: an emerging concept","volume":"10","author":"Emsley","year":"2010","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.mehy.2014.03.015_b0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.31.6.1223","article-title":"Medical complications after stroke: a multicenter study","volume":"31","author":"Langhorne","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2014.03.015_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02918615","article-title":"Neuroendocrine\u2013immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients","volume":"11","author":"Cruse","year":"1992","journal-title":"Immunol Res"},{"key":"10.1016\/j.mehy.2014.03.015_b0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01616412.1991.11739977","article-title":"Humoral and cellular immunity following severe head injury: review and current investigations","volume":"13","author":"Miller","year":"1991","journal-title":"Neurol Res"},{"key":"10.1016\/j.mehy.2014.03.015_b0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3171\/jns.2001.94.5.0706","article-title":"Early immunological defects in comatose patients after acute brain injury","volume":"94","author":"Wolach","year":"2001","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.mehy.2014.03.015_b0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrn1765","article-title":"Central nervous system injury-induced immune deficiency syndrome","volume":"6","author":"Meisel","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"1438","key":"10.1016\/j.mehy.2014.03.015_b0035","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","article-title":"Inflammation in central nervous system injury","volume":"358","author":"Allan","year":"2003","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"10","key":"10.1016\/j.mehy.2014.03.015_b0040","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1161\/STROKEAHA.109.557967","article-title":"Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection","volume":"40","author":"Hug","year":"2009","journal-title":"Stroke"},{"issue":"Suppl. 2","key":"10.1016\/j.mehy.2014.03.015_b0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.STR.0000251441.89665.bc","article-title":"Stroke-induced immunodepression: experimental evidence and clinical relevance","volume":"38","author":"Dirnagl","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2014.03.015_b0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","article-title":"Experimental stroke induces massive, rapid activation of the peripheral immune system","volume":"26","author":"Offner","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mehy.2014.03.015_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(03)00134-6","article-title":"An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis","volume":"139","author":"Emsley","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2014.03.015_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.mehy.2014.03.015_b0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijcard.2010.10.053","article-title":"Immune responses after acute ischemic stroke or myocardial infarction","volume":"155","author":"Haeusler","year":"2010","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.mehy.2014.03.015_b0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.03.015_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2010.09.023","article-title":"Immunological consequences of ischemic stroke: immunosuppression and autoimmunity","volume":"231","author":"Vogelgesang","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2014.03.015_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-14-1","article-title":"Cytotoxic function of CD8+ T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke-induced immunosuppression","volume":"14","author":"Li","year":"2013","journal-title":"BMC Immunol"},{"issue":"2105\u20132112","key":"10.1016\/j.mehy.2014.03.015_b0085","first-page":"17","article-title":"Role of T lymphocytes and interferon-gamma in ischemic stroke","volume":"113","author":"Yilmaz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2014.03.015_b0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.STR.0000258346.68966.9d","article-title":"Infection after acute ischemic stroke: a mani- festation of brain-induced immunodepression","volume":"38","author":"Chamorro","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2014.03.015_b0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021098","article-title":"Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation","volume":"198","author":"Prass","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2014.03.015_b0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0026-895X(25)13196-9","article-title":"Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model","volume":"33","author":"Howlett","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.febslet.2004.10.064","article-title":"Echinacea alkylamides modulate TNF-gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways","volume":"577","author":"Gertsch","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2014.03.015_b0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2014.03.015_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"Gerard","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.mehy.2014.03.015_b0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09130-8","article-title":"Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation","volume":"42","author":"Kaminski","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.mehy.2014.03.015_b0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2014.03.015_b0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(01)01122-0","article-title":"Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation","volume":"423","author":"Lee","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2014.03.015_b0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/187153010791936874","article-title":"The cannabinoid 2 receptor as a potential therapeutic target for sepsis","volume":"10","author":"Kasten","year":"2010","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.mehy.2014.03.015_b0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/039463201002300103","article-title":"Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry","volume":"23","author":"Graham","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2\u2013arachidonoylglycerol and their possible physiological significance","volume":"66","author":"Sugiura","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.mehy.2014.03.015_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.02.013","article-title":"Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities","volume":"80","author":"Bosier","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.015_b0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2014.03.015_b0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.2001.5015","article-title":"Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock","volume":"294","author":"Wang","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.mehy.2014.03.015_b0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.psyneuen.2008.02.009","article-title":"Anandamide and neutrophil function in patients with fibromyalgia","volume":"33","author":"Kaufmann","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.mehy.2014.03.015_b0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jlb.67.4.520","article-title":"Activation of cAMP-dependent protein kinase is necessary for actin rearrangements in human neutrophils during phagocytosis","volume":"67","author":"Ydrenius","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.mehy.2014.03.015_b0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","article-title":"The cannabinoid receptor 2 is critical for the host response to sepsis","volume":"183","author":"Tsch\u00f6p","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2014.03.015_b0200","first-page":"87","article-title":"Inflammation in stroke: the good, the bad, and the unknown","volume":"47","author":"Dirnagl","year":"2004","journal-title":"Ernst Schering Res Found Workshop"},{"issue":"2","key":"10.1016\/j.mehy.2014.03.015_b0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/01.STR.0000200561.69611.f8","article-title":"The harms and benefits of inflammatory and immune responses in vascular disease","volume":"37","author":"Chamorro","year":"2006","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.mehy.2014.03.015_b0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.mehy.2014.03.015_b0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2009.03.019","article-title":"Endocannabinoids and immune regulation","volume":"60","author":"Pandey","year":"2009","journal-title":"Pharmacol Res"},{"issue":"23","key":"10.1016\/j.mehy.2014.03.015_b0220","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2174\/138161208785740054","article-title":"Role of cannabinoids and endocannabinoids in cerebral ischemia","volume":"14","author":"Hillard","year":"2008","journal-title":"Curr Pharm Des"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:47:49Z","timestamp":1746157669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0306987714001170"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.03.015","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}